And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...

FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...

Welcome to the new Food and Drug Administration as envisioned by Dr. Marty Makary, who is leading the agency under Health Secretary Robert F. Kennedy Jr. Both men have said they want to overhaul ...

The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ ...

Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...

US regulators, under the guidance of FDA Commissioner Marty Makary, are launching a program to accelerate drug approvals, ...

According to an internal email, the agency may be in for more consolidation in areas including human resources, ...

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.